ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC, Robert VLACHOVSKÝ, Igor GUŇKA, Pavel NAVRÁTIL, Filip THIEME, Petr MITÁŠ, Rudolf ŠPUNDA, Jaroslav ŠPATENKA, Robert STAFFA, Petr NĚMEC and Jaroslav LINDNER. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell and Tissue Banking. Dordrecht: Springer, 2018, vol. 19, No 3, p. 437-445. ISSN 1389-9333. Available from: https://dx.doi.org/10.1007/s10561-018-9691-4.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic
Authors ŠPAČEK, Miroslav (203 Czech Republic, guarantor), Pavel SMĚŘIČKA (203 Czech Republic), Libor JANOUŠEK (203 Czech Republic), Petr ŠTÁDLER (203 Czech Republic), Miloš ADAMEC (203 Czech Republic), Robert VLACHOVSKÝ (203 Czech Republic, belonging to the institution), Igor GUŇKA (203 Czech Republic), Pavel NAVRÁTIL (203 Czech Republic), Filip THIEME (203 Czech Republic), Petr MITÁŠ (203 Czech Republic), Rudolf ŠPUNDA (203 Czech Republic), Jaroslav ŠPATENKA (203 Czech Republic), Robert STAFFA (203 Czech Republic, belonging to the institution), Petr NĚMEC (203 Czech Republic) and Jaroslav LINDNER (203 Czech Republic).
Edition Cell and Tissue Banking, Dordrecht, Springer, 2018, 1389-9333.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.939
RIV identification code RIV/00216224:14110/18:00104200
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s10561-018-9691-4
UT WoS 000442599400018
Keywords in English Vascular allograft; Cryopreservation; Tissue transplantation; Organization model
Tags 14110121, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 17:08.
Abstract
The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.
PrintDisplayed: 21/7/2024 16:33